Phase III Study of Adjuvant Capecitabine vs Observation Alone in Curatively Resected Stage IB (by AJCC 6th Edition) Gastric Cancer(KCSG ST14-05)
Phase of Trial: Phase III
Latest Information Update: 17 Oct 2019
Price : $35 *
At a glance
- Drugs Capecitabine (Primary)
- Indications Adenocarcinoma; Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- Acronyms CATALYSIS; KCSG ST14-05
- 13 Oct 2019 Planned End Date changed from 1 Aug 2021 to 1 Aug 2026.
- 13 Oct 2019 Planned primary completion date changed from 1 Aug 2021 to 1 Aug 2026.
- 29 May 2015 Trial design presented at 51st Annual Meeting of the American Society of Clinical Oncology.